Penetrium Bioscience Amends Capital Increase Schedule
페니트리움바이오
187660
Signal Score
Historical Avg Return (5d)
+0.72%
Data Coverage
100%n=2249
Risk-adjusted indicator based on 2249 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • New Share Allotment Record Date: June 16, 2026 (Changed from June 5, 2026)
- • Old Shareholder Subscription Start Date: July 22, 2026 (Changed from July 9, 2026)
3 more figures — Starter & Pro plans
AI Analysis Summary
Penetrium Bioscience Inc. has filed an amendment to its Material Fact Report regarding a paid-in capital increase. The key changes involve a postponement of the new share allotment record date to June 16, 2026, and the old shareholder subscription period to July 22-23, 2026. The final issue price determination date has also been pushed to July 16, 2026. The issue price will be determined with a 25% discount rate. While the capital increase itself is dilutive, this amendment primarily concerns schedule adjustments, leading to a neutral financial impact.
Risk Factors
Pro plan
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Price reaction & historical pattern data
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.